Session Overview

In vitro tumor models have provided important tools for cancer research and serve as low-cost screening platforms for drug therapies; however, cancer recurrence remains largely unchecked due to metastasis, which is the cause of the majority of cancer-related deaths. The need for an improved understanding of the progression and treatment of cancer has pushed for increased accuracy and physiological relevance of in vitro tumor models. This session welcomes speakers looking to address this need with their research.

Session Chair: DR MIRIAM DWEK

LEADER - CANCER RESEARCH GROUP

UNIVERSITY OF WESTMINSTER

My current research interests are in the area of cancer biomarker discovery, the development of new approaches for the in silico and in vitro study of breast cancer behaviour, diet and lifestyle aspects of breast cancer progression.

Keynote Speaker: PROFESSOR FRAN BALKWILL OBE

CENTRE LEAD, CENTRE FOR CANCER AND INFLAMMATION / INSTITUTE OF BIOENGINEERING DIRECTOR OF RESEARCH STRATEGY

QUEEN MARY UNIVERSITY LONDON

Presentation title: Modelling the Tumour Microenvironment of High-Grade Serous Ovarian Cancer

The Presenters

 

DR CARSTEN HANSEN

Chancellor's Fellow

Centre for Inflammation Research

University of Edinburgh

Presentation Title: Mechanotransduction in the Hippo pathway

DR Manuela Natoli

Senior Research Associate

CRUK Cambridge Centre

Title: Cell Culture quality controls: 10 years of centralised cell line management

 

DR MICHELE ZAGNONI

SENIOR LECTURER

UNIVERSITY STRATHCLYDE

Presentation title: Oncoscreen: a microfluidic solution for personalised oncology

DR Maria Vias

Senior Scientific Officer

CRUK Cambridge Center

Presentation Title: Human primary high grade serous ovarian carcinoma organoid cultures for disease modelling and drug screening

 

Dr Adrian Biddle

LECTURER, BLIZZARD INSTITUTE,

QUEEN MARY UNIVERSITY LONDON

Presentation Title : In vitro modelling of cancer stem cell therapeutic responses for drug discovery

REGISTER NOW